Skip to main navigation Skip to search Skip to main content

Resolving the Fas counterattack controversy: Fas ligand promotes tumour immune evasion of colon cancer in vivo

Research output: Chapter in Book or Conference Publication/ProceedingConference Publicationpeer-review

Abstract

Resolving the Fas counterattack controversy: Fas ligand promotes tumour immune evasion of colon cancer in vivo
Original languageEnglish (Ireland)
Title of host publicationEndoscopy
Place of Publication 10.1055/s-2005-922880
Publication statusPublished - 1 Jan 2005

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Authors (Note for portal: view the doc link for the full list of authors)

  • Authors
  • Ryan AE, Shanahan F, OConnell J, Houston AM

Fingerprint

Dive into the research topics of 'Resolving the Fas counterattack controversy: Fas ligand promotes tumour immune evasion of colon cancer in vivo'. Together they form a unique fingerprint.

Cite this